%0 Journal Article %T Enfermedad de Coats tratada con bevacizumab (Avastin£¿) %A ¨¢lvarez-Rivera %A L.G. %A Abraham-Mar¨ªn %A M.L. %A Flores-Orta %A H.J. %A Mayorqu¨ªn-Ruiz %A M. %A Cort¨¦s-Luna %A C.F. %J Archivos de la Sociedad Espa£¿ola de Oftalmolog¨ªa %D 2008 %I Scientific Electronic Library Online %R 10.4321/S0365-66912008000500010 %X case report: we report a case of coats£¿ disease in a 10-year-old-girl who presented with a profound visual deficit, exudative retinal detachment, vascular telangiectasias and subretinal lipid, who underwent treatment with an intravitreal injection of bevacizumab (avastin£¿). serial examinations documented an involutional response with a reduction of the subretinal fluid, exudates and macular thickness. discussion: the aetiology of coats£¿ disease remains uncertain, as does its optimal management. although resolution of a case depends partially on age, and can even occur spontaneously on rare occasions, intravitreal injections of bevacizumab should be considered when planning treatment. %K vascular endothelial growth factor %K coats£¿ disease %K monoclonal antibodies %K angiogenesis inhibitors %K telangiectatic retinal vessels. %U http://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S0365-66912008000500010&lng=en&nrm=iso&tlng=en